Published in Hum Reprod on October 01, 1999
Non-negative matrix analysis for effective feature extraction in X-ray spectromicroscopy. Faraday Discuss (2014) 0.90
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89
Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys (1975) 2.85
Lifespan and testosterone. Nature (1993) 2.84
Flow cytometry in clinical cancer research. Cancer Res (1983) 2.72
Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature (1996) 2.63
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev (1997) 2.44
Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism. Hum Reprod (1997) 2.23
Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating. Br J Haematol (2000) 2.18
Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod (1998) 2.10
Sex determination in dioecious plants Melandrium album and M. rubrum using high-resolution flow cytometry. Cytometry (1995) 2.08
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98
Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod (2000) 1.96
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91
[Impulse fluorometry of single cells in suspension]. Z Naturforsch B (1969) 1.80
External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65
Cellular DNA content as a marker of neoplasia in man. Am J Med (1980) 1.62
The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric (2000) 1.62
Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod (1999) 1.61
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab (1997) 1.54
Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53
Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum Mol Genet (2000) 1.53
Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45
Sonographic testicular microlithiasis as an indicator of premalignant conditions in normal and infertile men. J Androl (2001) 1.45
Objective identification of hyperactivated human spermatozoa by computerized sperm motion analysis with the Hamilton-Thorn sperm motility analyser. Hum Reprod (1990) 1.42
A portable digital data recorder for long-term monitoring of scrotal temperatures. Fertil Steril (1990) 1.42
The epididymis and male fertility. A symposium report. Int J Androl (1986) 1.41
The effect of bradykinin and the bradykinin antagonist Hoe 140 on kinematic parameters of human spermatozoa. Int J Androl (1996) 1.40
[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39
Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet (1997) 1.38
Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet (1984) 1.36
Testosterone replacement therapy: current trends and future directions. Hum Reprod Update (2004) 1.33
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update (2002) 1.30
Germ cell transfer into rat, bovine, monkey and human testes. Hum Reprod (1999) 1.30
Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol (2001) 1.30
Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol (Copenh) (1975) 1.26
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26
Germ cell transplantation into X-irradiated monkey testes. Hum Reprod (2002) 1.25
Partial deletions in the AZFc region of the Y chromosome occur in men with impaired as well as normal spermatogenesis. Hum Reprod (2004) 1.24
Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol (2001) 1.24
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab (1999) 1.20
Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res (1978) 1.18
Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl (1989) 1.17
Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab (1982) 1.17
The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. Genomics (1996) 1.14
Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril (2000) 1.14
DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry (1998) 1.13
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod (2001) 1.12
The "vanishing counting bead" phenomenon: effect on absolute CD34+ cell counting in phosphate-buffered saline-diluted leukapheresis samples. Cytometry (2001) 1.11
Steroid hormones and their binding in plasma of male patients with fatty liver, chronic hepatitis and liver cirrhosis. Acta Endocrinol (Copenh) (1975) 1.11
Experience with external quality control in spermatology. Hum Reprod (1999) 1.11
Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet (2008) 1.10
The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia (2002) 1.10
A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab (2005) 1.09
Semen analysis and external quality control schemes for semen analysis need global standardization. Int J Androl (2002) 1.06
Evaluation of the semi-automated Autosperm semen analysis system. I. Accuracy and comparison with the conventional method and the automated Hamilton-Thorn system. Fertil Steril (1990) 1.06
Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy. Int J Androl (2010) 1.06
Spontaneous recrudescence of spermatogenesis in the photoinhibited male Djungarian hamster, Phodopus sungorus. Biol Reprod (1995) 1.06
Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05
Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol (2005) 1.04
The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab (2001) 1.04
Anabolic steroids and semen parameters in bodybuilders. Fertil Steril (1989) 1.04
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl (2005) 1.03
Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab (2000) 1.03
Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol (Oxf) (1999) 1.03
An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab (1996) 1.03
Influence of short photoperiods on reproductive organs and estrous cycles of normal and pinealectomized female Djungarian hamsters, Phodopus sungorus. Biol Reprod (1993) 1.02
Internal quality control of semen analysis. Fertil Steril (1992) 1.02
Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab (1999) 1.02
[Pulse cytophotometry of DNA in skin tumours]. Arch Klin Exp Dermatol (1971) 1.01
Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod (1998) 1.01
Measurement of mammalian sperm deoxyribonucleic acid by flow cytometry. Problems and approaches. J Histochem Cytochem (1977) 1.01
The Old World monkey DAZ (Deleted in AZoospermia) gene yields insights into the evolution of the DAZ gene cluster on the human Y chromosome. Hum Mol Genet (1999) 1.00
Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract (1985) 0.99
Identification of male germ cells undergoing apoptosis in adult rats. J Reprod Fertil (1995) 0.99
Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene (2006) 0.98
The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer (1990) 0.98
Hormone substitution in male hypogonadism. Mol Cell Endocrinol (2000) 0.98